Research programme: anti-B-cell receptor monoclonal antibodies - GenitopeAlternative Names: Anti-BCR monoclonal antibodies; Non-Hodgkin's lymphoma therapeutics - Genitope
Latest Information Update: 24 Dec 2013
At a glance
- Originator Genitope Corporation
- Class Monoclonal antibodies
- Mechanism of Action B cell inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma